The 20 Best Melanoma Doctors in District of Columbia, US

Geoffrey Gibney is an Oncologist in Washington, Washington, D.c.. Dr. Gibney is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Sinus Cancer, and Olfactory Neuroblastoma.

Michael Atkins is an Oncologist in Washington, Washington, D.c.. Dr. Atkins is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Nephrectomy.

Agnes Chang is a Dermatologist in Washington, Washington, D.c.. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus.

Dr. Mary Ella M. Carter is a plastic surgeon affiliated with Sibley Memorial Hospital. She has a private practice in Sibley Memorial Hospital’s Medical Building in Washington, D.C. Dr. Carter has an expertise in aesthetic and cosmetic plastic surgery, breast reconstruction and facial plastic and reconstructive surgery. She also works with skin cancer and melanoma. Dr. Carter earned her medical degree from Georgetown University Hospital. She completed a residency in plastic surgery at Georgetown University School of Medicine. Dr. Carter is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Melanoma, and Epidural Lipomatosis.

Stephen Suah is a Dermatologist in Washington, Washington, D.c.. Dr. Suah is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Systemic Capillary Leak Syndrome, Hepatic Hemangioma, and Fox-Fordyce Disease.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Suthee Rapisuwon is a Hematologist in Washington, Washington, D.c.. Dr. Rapisuwon is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Renal Cell Carcinoma (RCC).

Sarika Snell is a Dermatologist in Washington, Washington, D.c.. Dr. Snell is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Comedones, Universal Acquired Melanosis, and Liver Spots.

Lauren Mckelroy is a Dermatologist in Washington, Washington, D.c.. Dr. Mckelroy is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Malignant Hypertension, Female Pattern Baldness, Melanoma, and Comedones.

Clinzo Mickle is a Dermatologist in Washington, Washington, D.c.. Dr. Mickle is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Malignant Hypertension, Female Pattern Baldness, Melanoma, and Familial Atypical Multiple Mole Melanoma Syndrome.

Urvi Gonzales is a Dermatologist in Washington, Washington, D.c.. Dr. Gonzales is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Fetal Cystic Hygroma, Kaposiform Hemangioendothelioma, Tufted Angioma, and Hemangioma.

Tinatin Gotsiridze is a Dermatologist in Washington, Washington, D.c.. Dr. Gotsiridze has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Atopic Dermatitis, Comedones, Malignant Hypertension, and Female Pattern Baldness.

Sandra Read is a Dermatologist in Washington, Washington, D.c.. Dr. Read is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Spider Angioma, Telangiectasia, Melanoma, and Giant Congenital Nevus.

Stefan Schieke is a Dermatologist in Washington, Washington, D.c.. Dr. Schieke is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Mycosis Fungoides, Parapsoriasis, Lymphomatoid Papulosis, and T-Cell Lymphoma.

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy.

Larissa Korde is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Korde is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Breast Cancer, Breast Cancer in Men, Inflammatory Breast Cancer, and Menopause.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Breast Cancer, and Familial Pancreatic Cancer.

Kevin Sharghi, M.D. is a Johns Hopkins dermatologist located at Sibley Memorial Hospital in Washington, D.C. His expertise is in medical dermatology. Dr. Sharghi sees both adults and children of all ages. He obtained his medical degree at The University of Texas Medical Branch and completed his dermatology residency at Virginia Tech Carilion School of Medicine. Videos Psoriasis and Psoriasis Arthritis FAQ Cutaneous Side Effects of Chemotherapies and ImmunotherapiesWhat Providers Need to Know. Dr. Sharghi is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Seborrheic Keratosis, Warts, Sunburn, and Bullae.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.